Use the search parameters below to filter talks:

Calendar
Calendar

2012 - TTS International Congress (Berlin)

Late Breaking Abstracts - Kidney
16 July 2012  /  15:30 - 17:00

of High-Performance-Liquid Chromatography-Tandem Mass Spectrometry (HPLC-TMS) versus Fluorescent Polarization Immunoassay (FPIA) for Therapeutic Drug Monitoring of Tacrolimus in Kidney Transplant Recipients

Presenter: Petrina Fan, ,

- of High-Performance-Liquid Chromatography-Tandem Mass Spectrometry (HPLC-TMS) versus Fluorescent Polarization Immunoassay (FPIA) for Therapeutic Drug Monitoring of Tacrolimus in Kidney Transplant Recipients

Presenter: Petrina Fan, ,

Urinary Connective Tissue Growth Factor (CTGFu) as a Marker and Early Predictor of Chronic Renal Allograft Injury

Presenter: Dirk Kuypers, ,

- Urinary Connective Tissue Growth Factor (CTGFu) as a Marker and Early Predictor of Chronic Renal Allograft Injury

Presenter: Dirk Kuypers, ,

Outcomes from Combining Kidney Paired Donation and Desensitization: An Approach to Kidney Transplantation for the Most Highly Sensitized Patients

Presenter: Adnan Sharif, ,

- Outcomes from Combining Kidney Paired Donation and Desensitization: An Approach to Kidney Transplantation for the Most Highly Sensitized Patients

Presenter: Adnan Sharif, ,

Tacrolimus Prolonged Release Optimises Exposure During the Immediate Postoperative Period

Presenter: Bernhard Banas, ,

- Tacrolimus Prolonged Release Optimises Exposure During the Immediate Postoperative Period

Presenter: Bernhard Banas, ,

Phase 1b, Randomized, Double-Blind, Parallel Group, Placebo-Controlled, Single-Dose, Pharmacokinetic, Pharmacodynamic, Safety and Tolerability Study of ASKP1240 in de novo Kidney Transplantation

Presenter: Flavio Vincenti, ,

- Phase 1b, Randomized, Double-Blind, Parallel Group, Placebo-Controlled, Single-Dose, Pharmacokinetic, Pharmacodynamic, Safety and Tolerability Study of ASKP1240 in de novo Kidney Transplantation

Presenter: Flavio Vincenti, ,

Association of Interferon-? and Tumor Necrosis Factor-? Cytokine Gene Polymorphisms with Symptomatic BK Virus Infection

Presenter: Ian V. Hutchinson, ,

- Association of Interferon-? and Tumor Necrosis Factor-? Cytokine Gene Polymorphisms with Symptomatic BK Virus Infection

Presenter: Ian V. Hutchinson, ,

Immunosuppression in Liver Transplantation
16 July 2012  /  15:30 - 17:00

Impact of Early Everolimus-Facilitated Reduction or Elimination of Tacrolimus on the Evolution of Renal Function in 719 De Novo Liver Transplant Recipients: 12 Month Data of the H2304 Study

Presenter: Herold Metselaar, ,

- Impact of Early Everolimus-Facilitated Reduction or Elimination of Tacrolimus on the Evolution of Renal Function in 719 De Novo Liver Transplant Recipients: 12 Month Data of the H2304 Study

Presenter: Herold Metselaar, ,

Sirolimus Monotherapy in Liver Transplantation

Presenter: Cristina Alegre Torrado, ,

- Sirolimus Monotherapy in Liver Transplantation

Presenter: Cristina Alegre Torrado, ,

Sirolimus Monotherapy in Liver Transplant Recipients with De Novo Tumors

Presenter: Cristina Alegre Torrado, ,

- Sirolimus Monotherapy in Liver Transplant Recipients with De Novo Tumors

Presenter: Cristina Alegre Torrado, ,

Immunosuppressive Monotherapy with Everolimus in Liver Transplantation

Presenter: Cristina Alegre Torrado, ,

- Immunosuppressive Monotherapy with Everolimus in Liver Transplantation

Presenter: Cristina Alegre Torrado, ,

Efficacy and Safety of Conversion from Tacrolimus Twice-Daily (Prograf®) to Tacrolimus Once-Daily Prolonged-Released (Advagraf®) in Liver Transplantation. An Italian Single-Center Experience

Presenter: Riccardo Volpes, ,

- Efficacy and Safety of Conversion from Tacrolimus Twice-Daily (Prograf®) to Tacrolimus Once-Daily Prolonged-Released (Advagraf®) in Liver Transplantation. An Italian Single-Center Experience

Presenter: Riccardo Volpes, ,

Two Years Follow Up after Conversion 1:1 from Twice to Once-Daily Tacrolimus in Liver Transplantation: Quality of Life, Patients´ Compliance and Drug Efficacy Evaluation

Presenter: Luca Toti, ,

- Two Years Follow Up after Conversion 1:1 from Twice to Once-Daily Tacrolimus in Liver Transplantation: Quality of Life, Patients´ Compliance and Drug Efficacy Evaluation

Presenter: Luca Toti, ,

Potencial antifibrotic Effect of Long-Term Everolimus Based Immunosuppression in HCV Positive Liver Transplant Patients

Presenter: Cristina Dopazo, ,

- Potencial antifibrotic Effect of Long-Term Everolimus Based Immunosuppression in HCV Positive Liver Transplant Patients

Presenter: Cristina Dopazo, ,

Delayed Introduction of Everolimus Versus Tacrolimus in de Novo Liver Transplant Recipients: Safety Events of Interest with Everolimus Use

Presenter: L Fischer, ,

- Delayed Introduction of Everolimus Versus Tacrolimus in de Novo Liver Transplant Recipients: Safety Events of Interest with Everolimus Use

Presenter: L Fischer, ,

Pediatric Renal Transplantation
16 July 2012  /  15:30 - 17:00

Intragraft B-Cells Are Associated with Medication Nonadherence and Severity of Rejection in Pediatric Kidney Transplant Recipients

Presenter: Rhiana Lau, ,

- Intragraft B-Cells Are Associated with Medication Nonadherence and Severity of Rejection in Pediatric Kidney Transplant Recipients

Presenter: Rhiana Lau, ,

Enhanced Sensitivity to Cyclosporine-Induced Suppression of Intracellular Interleukin-2 Expression In Vivo in Paediatric vs. Adult Renal Transplant Recipients

Presenter: Heiko Billing, ,

- Enhanced Sensitivity to Cyclosporine-Induced Suppression of Intracellular Interleukin-2 Expression In Vivo in Paediatric vs. Adult Renal Transplant Recipients

Presenter: Heiko Billing, ,

IVIG and Rituximab for Treatment of Chronic Antibody-Mediated Rejection in Pediatric Renal Transplantation: A Prospective Pilot Study with a 2 Year Follow-Up

Presenter: Heiko Billing, ,

- IVIG and Rituximab for Treatment of Chronic Antibody-Mediated Rejection in Pediatric Renal Transplantation: A Prospective Pilot Study with a 2 Year Follow-Up

Presenter: Heiko Billing, ,

Rituximab Therapy and Infection Risk in Pediatric Renal Transplant Patients

Presenter: Esra Baskin, ,

- Rituximab Therapy and Infection Risk in Pediatric Renal Transplant Patients

Presenter: Esra Baskin, ,

Alemtuzumab Induction in Pediatric Kidney Transplantation

Presenter: Michael Kaabak, ,

- Alemtuzumab Induction in Pediatric Kidney Transplantation

Presenter: Michael Kaabak, ,

Outcomes and Predictive Factors of 201 Pediatric Kidney Transplants: A Report of Thai Transplant Registry

Presenter: Pornpimol Rianthavorn, ,

- Outcomes and Predictive Factors of 201 Pediatric Kidney Transplants: A Report of Thai Transplant Registry

Presenter: Pornpimol Rianthavorn, ,

Our Corporate Sponsors

TTS gratefully acknowledges the Corporate Partners whose generous support makes the work of the Society possible:

  • astellas
  • roche
  • sanofi